In AD patients, CD200 and CD200R are found to be downregulated in postmortem brain tissue [62], and the viral expression of CD200 in the hippocampi of APP/PS1 mice improves cognitive functions by promoting synaptic plasticity [63]. This evidence concerns the gene APP and Alzheimer disease.